Back
Compare AU
Compare QAU vs. DRUG
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Betashares Gold Bullion Currency Hedged ETF (QAU) and the Betashares Global Healthcare Currency Hedged ETF (DRUG). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
QAU | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 178 | 74 |
Median incremental investment | $1,095.41 | $740.50 |
Median investment frequency | Monthly | Monthly |
Median total investment | $2,054.00 | $1,964.60 |
Average age group | > 35 | 26 - 35 |
Key Summary
QAU | DRUG | |
|---|---|---|
Strategy | QAU.AX was created on 2011-05-03 by BetaShares. The fund's investment portfolio concentrates primarily on gold commodities. The investment objective of the Fund is to provide an investment return, before fees and expenses, that closely tracks the performance of the price of gold bullion, with a currency hedge against movements in the AUD/USD exchange rate. | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. |
Top 3 holdings | AUD - AUSTRALIA DOLLAR (100.21 %) LONDON GOLD MARKET FIXING LTD GOLD BULLION GOLD BULLION (95.01 %) USD - UNITED STATES DOLLAR (-95.22 %) | AUD - AUSTRALIA DOLLAR (0 %) BRL - BRAZILIAN REAL (0 %) CHF - SWISS FRANC (0 %) |
Top 3 industries | Other (66.71 %) Communication Services (33.29 %) | Other (75.91 %) Communication Services (33.53 %) Health Care (23.80 %) |
Top 3 countries | United States (69.91 %) Switzerland (10.93 %) United Kingdom of Great Britain and Northern Ireland (7.38 %) | |
Management fee | 0.59 % | 0.57 % |
Key Summary
QAU | DRUG | |
|---|---|---|
Issuer | BetaShares | BetaShares |
Tracking index | LBMA Gold Price AM ($/ozt) | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.59 % | 0.57 % |
Price | $39.50 | $8.93 |
Size | $1.674 billion | $182.424 million |
10Y return | 214.24 % | N/A |
Annual distribution yield (5Y) | 2.38 % | 1.92 % |
Market | ASX | ASX |
First listed date | 04/05/2011 | 08/08/2016 |
Purchase fee | $6.50 | $6.50 |
Community Stats
QAU | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 178 | 74 |
Median incremental investment | $1,095.41 | $740.50 |
Median investment frequency | Monthly | Monthly |
Median total investment | $2,054.00 | $1,964.60 |
Average age group | > 35 | 26 - 35 |
Pros and Cons
QAU | DRUG | |
|---|---|---|
Pros |
|
|
Cons |
|
|
QAU | DRUG |
|---|---|
Lower exposure to US market | Higher exposure to US market |
Higher management fee | Lower management fee |
Higher price growth | Lower price growth |
Higher distribution yield | Lower distribution yield |